| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $37.90B | +8.7% |
| Cost of Revenue | $8.64B | +1.2% |
| Gross Profit | $29.25B | +11.2% |
| R&D Expense | $5.49B | +12.0% |
| SG&A Expense | $2.84B | +11.9% |
| Operating Income | $7.21B | +43.8% |
| Interest Expense | $272.0M | -3.9% |
| Pre-tax Income | $7.44B | +50.3% |
| Income Tax | $1.24B |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.85B | +4.4% |
| Accounts Receivable | $11.95B | +4.7% |
| Current Assets | $29.73B | +2.2% |
| Total Assets | $102.93B | +3.1% |
| Current Liabilities | $27.98B | +5.1% |
| Long-term Debt | $8.43B | -10.5% |
| Total Liabilities | $41.76B | +3.9% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.09B | +27.9% |
| Capital Expenditures | $658.0M | -10.6% |
| Investing Cash Flow | -$3.16B | -138.4% |
| Financing Cash Flow | -$9.43B | -26.1% |
| Free Cash Flow | $12.43B | +30.9% |
| +52.5% |
| Net Income | $6.20B | +49.8% |
| EPS (Basic) | $6.44 | +51.5% |
| EPS (Diluted) | $6.36 | +51.4% |
| Stockholders' Equity |
| $61.17B |
| +2.6% |